Sea Sickness
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance (NCT05886660) | Repurposed Therapeutics, Inc. | 2022-01-21 |
| Video Head Impulse Test and Seasickness Susceptibility (NCT05657340) | Medical Corps, Israel Defense Force | 2019-01-01 |
| Motion Sickness on Astrolabe's Vessel (NCT02911402) | University Hospital, Caen | 2014-10-01 |
Track Sea Sickness automatically
Every clearance here is in the API, with alerts when new ones post.